article thumbnail

Embracing digitalization in the pharmaceutical supply chain

Pharmaceutical Technology

Digital technologies will be utilized throughout drug development, production, packaging and delivery for increased process efficiency and improved product quality. According to GlobalData, the number of mentions of ‘Artificial Intelligence’ in the company filings of pharmaceutical organizations increased 105% between 2016 and 2021.

article thumbnail

Merck makes circular RNA play with $3.5bn Orna alliance

pharmaphorum

The oRNAs can also be packaged into lipid nanoparticles, which can help with delivery and potentially can allow them to be targeted to specific tissues in the body. It says oRNA molecules are more stable in the body than linear mRNA sequences, and have the potential to produce larger amounts of therapeutic proteins.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Intellia, Regeneron ace first trial with ‘in vivo’ CRISPR drug

pharmaphorum

Intellia and Regeneron’s in vivo approach involves administration of a gene-editing drug – in the form of a CRISPR mRNA and guide RNA packaged in a lipid nanoparticle – directly into the body. Regeneron has partnered the company since 2016. . — Eric Topol (@EricTopol) June 26, 2021.

Packaging 105
article thumbnail

Hikma shares rally after US launch of Advair generic resumes

pharmaphorum

Advair lost US patent protection in 2010 and exclusivity on the Diskus inhaler went in 2016 – but it took until February 2019 for the FDA to approve a generic from Mylan, now part of Viatris. The amendment was required because of enhanced packaging controls to meet new industry standards adopted since the filing.

article thumbnail

RPS calls for mandatory training on learning disabilities and autism for pharmacists

Hospital Pharmacy Europe

In 2016, Oliver McGowan, a young autistic teenager with a mild learning disability, sadly died after having a severe reaction to medication which he and his family had asked for him not to receive. A second, easy read version of this proposed code of practice is open for consultation and will close on 16 October.

article thumbnail

EMA upgrades drug development innovation scheme to PRIME time

Pharmaceutical Technology

The European Medicines Agency (EMA) has announced plans to expedite scientific advice and support the preparation of regulatory packages under its PRIority Medicines (PRIME) scheme. The PRIME scheme, launched in March 2016, gives applicants a number of exclusive benefits to help reach regulatory approval.

article thumbnail

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

According to the report, five member companies decided to decrease their investment in Japan between 2016 and 2017, four companies changed their investment targets between 2018 and 2020, and one company lowered the priority given to Japan after 2021.